A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3
Year: 2005
Type: article
Source: Molecular Cancer Therapeutics
Authors: Xenia Jimenez, Dan Lu, Laura Brennan, Kris Persaud, Meilin Liu, Huaquan Miao, Larry Witte, Zhenping Zhu
Institution: Recombinant Antibody Technology (United Kingdom)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2184879005